MOLECULAR AND THERAPEUTIC ADVANCES IN THE MANAGEMENT OF CHRONIC HEPATITIS-B AND HEPATITIS-C

Authors
MCCARRON B MAIN J THOMAS HC
Citation
B. Mccarron et al., MOLECULAR AND THERAPEUTIC ADVANCES IN THE MANAGEMENT OF CHRONIC HEPATITIS-B AND HEPATITIS-C, Current opinion in infectious diseases, 11(5), 1998, pp. 555-564
Citations number
149
Categorie Soggetti
Infectious Diseases
Journal title
Current opinion in infectious diseases → ACNP
ISSN journal
09517375
Volume
11
Issue
5
Year of publication
1998
Pages
555 - 564
Database
ISI
SICI code
0951-7375(1998)11:5<555:MATAIT>2.0.ZU;2-2
Abstract
Three hundred million individuals worldwide have persistent hepatitis B virus infection with 1-2 million hepatitis B virus-associated deaths per year, and an estimated 1% of the world's population are infected with hepatitis C virus. Recent advances in molecular biology and host responses have led to an increased understanding of hepatitis B and C virus disease and new potential targets for therapy. Curt Coin Infect Dis 11:555-564. (C) 1998 Lippincott Williams & Wilkins.